#Example 1
PREFIX bio-prov:<http://bioprovenance.org>
PREFIX sio:<http://semanticscience.org/resource/>
PREFIX rdfs:<http://www.w3.org/2000/01/rdf-schema#>
PREFIX xsd:<http://www.w3.org/2001/XMLSchema#>
PREFIX drugbank:<http://bio2rdf.org/drugbank_vocabulary:>
bio-prov:assertion1 
	a 						sio:assertion ;
	rdfs:label  					"Acetaminophen inhibits Prostaglandin G/H synthase 1" .		   
bio-prov:assertion1		
	bio-prov:assertedBy         		  	"Regina M. Botting"@en ; 
	bio-prov:coAssertedBy         			"Samir S. Ayoub"@en ; 
	bio-prov:assertedOn        			"2004-11-23"^^xsd:date ; 
	bio-prov:publishedOn        		   	"2004-11-23"^^xsd:date ; 
	bio-prov:wasInferredFrom			 assertion2 ; 
	bio-prov:publishedIn        		   	"Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"@en ; 
	bio-prov:publisher	        		"Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"@en ; 
	bio-prov:publicationTitle			 "COX-3 and the mechanism of action of paracetamol/acetaminophen"@en ; 
	bio-prov:retrievedFrom        		  	 "Drugbank"@en ; 
	bio-prov:retrievalURL        		    	 drugbank:DB00316-BE0000017 ; 
	bio-prov:databaseURL        		    	 "https://www.drugbank.ca" ; 
	bio-prov:databaseLicense			 "https://creativecommons.org/licenses/by-nc/4.0/legalcode" ; 
	bio-prov:databaseVersion			 "5.1.1"^^xsd:int ; 
	bio-prov:supportedByDataSet			  drugbank:DB00316-BE0000017 ; 
  	bio-prov:supportingDatasetLicense	  	  "https://creativecommons.org/licenses/by-nc/4.0/legalcode" ; 
  	bio-prov:supportingDatasetURL		    	  drugbank:DB00316-BE0000017 ; 
  	bio-prov:supportingDatasetVersion	  	  "5.1.1"^^xsd:int .

#Example 2
PREFIX bio-prov: <http://bioprovenance.org>
PREFIX sio:<http://semanticscience.org/resource/ >
PREFIX rdfs:<http://www.w3.org/2000/01/rdf-schema#>
PREFIX xsd:<http://www.w3.org/2001/XMLSchema#>
PREFIX assertion:<http://bioprovenance.org/assertion/>
PREFIX drugbank:<http://bio2rdf.org/drugbank_vocabulary:>
bio-prov:assertion3 
	a 						sio:assertion ;
	rdfs:label  					"Mebendazole inhibits VEGFR2"@en .	
 bio-prov:assertion3	
 	bio-prov:assertedBy 				"Sivanesan Dakshanamurthy"@en ;
 	bio-prov:coAssertedBy				"Stephen W Byers"@en ;
 	bio-prov:assertedOn				"2012-07-25"^^xsd:date ;
 	bio-prov:publishedOn				"2012-07-25"^^xsd:date ;
 	bio-prov:wasDerivedFrom				"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419493/figure/F8/" ;
 	bio-prov:supportingAnalysisSoftware		"Graphpad Prism"@en ;
 	bio-prov:supportingAnalysisSoftwareVersion	"6.01"^^xsd:int ;
 	bio-prov:supportingAnalysisMethod		"Ligand docking"@en ;
 	bio-prov:supportingSoftwareLicense		"https://www.graphpad.com/how-to-buy" ;
 	bio-prov:publishedIn				"Journal of Medicinal Chemistry"@en ;
 	bio-prov:publisher				"NIH"@en ;
 	bio-prov:publicationTitle			"Predicting New Indications for Approved Drugs Using a Proteo-Chemometric Method"@en .

#Example 3
